喜旱莲子草对钉螺脂酶同工酶影响的初步研究

用不同浓度的喜旱莲子草水浸液处理钉螺24h,观察其灭螺效果,并用聚丙酰胺凝胶电泳技术比较研究了水浸液对钉螺酯酶同工酶的影响,结果表明:钉螺头足部肌肉的酯酶同工酶在低浓度(0.01g/L)时,活性较强,随水浸液处理浓度升高,活性迅速降低;而肝脏的酯酶同工酶在中等浓度(0.1g/L)时,活性最强,高浓度时(1g/L)有些酶带发生分解、消失。钉螺的死亡率则随着处理浓度的提高,急剧增大。喜旱莲子草干粉水浸液对钉螺酯酶同工酶影响明显,是引起钉螺中毒死亡的原因之一。这为喜旱莲子草作为新型植物灭螺剂的开发打下基础。     

Toxicological effects involved in risk assessment of rare earth lanthanum on roots of Vicia faba L. seedlings

Combined chemical analyses and biological measurements were utilized to investigate potential toxicological effects and possible mechanisms involved in risk assessment of rare earth elements (REEs) on Vicia faba L. seedlings, which were hydroponically cultivated and exposed to various concentrations of lanthanum (La) for 15 days. The results showed that La contents in both the solution and roots increased with the increase of extraneous La, contributing to hormetic dose responses of superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (GPX), ascorbate peroxidase (APX) and endoprotease (EP) isozymes activities, and HSP 70 production enhanced at low doses but suppressed at higher doses of La. These physiological responses constituted antioxidant and detoxification systems against La-induced oxidative stress. The elevated La levels also contributed to oxidatively modified proteins, which were most responsible for subsequent cell death and growth retardation of the roots. By combination of hormetic and traditional threshold dose levels, the threshold dose range was deduced to be 108-195 μg La/g dry weight in the roots, corresponding to 0.90-3.12 mg/L of soluble La in the culture solution. It suggests that persistent applications of REEs may lead to potential ecological risk in the environment.     

联苯胺对线粒体抗氧化酶活性及同工酶的影响

不同浓度联苯胺(0.5,1.0,1.5,2.0mg/mL),以体外染毒方式作用于武昌鱼-团头鲂(Megalobrama amblycephala)肝脏线粒体,研究了武昌鱼肝脏线粒体两种主要抗氧化酶[谷胱甘肽过氧化物酶(GSH-Px)和超氧化物歧化酶(SOD)]活性的变化,用聚丙烯酰胺凝胶电泳法分析了其同工酶谱.结果显示0.5,1.0mg/mL联苯胺激活GSH-Px, 0.5mg/mL联苯胺激活SOD,而1.5, 2.0mg/mL联苯胺抑制这两种酶的活性;另外,在GSH-Px同工酶谱中呈现出特异性标志酶gsh4.     

Prenatal diagnosis of cystic fibrosis using a monoclonal antibody specific for intestinal alkaline phosphatase

A monoclonal antibody (AAP-1), specific for the intestinal isoenzyme of alkaline phosphatase (ALP), has been used to develop an immunoassay for amniotic fluid samples. Values in the immunoassay correlated closely with those obtained by direct determination of phenylalanine-inhibitable ALP. A panel of 124 control second-trimester amniotic fluids and 21 fluids with a 1 in 4 risk of a cystic fibrosis fetus were examined in the immunoassay. Eight of 10 affected cases had values below an arbitrary cut-off of one third median, while all the non-affected cases were above this level. Almost identical results were obtained by enzymatic determination of phenylalanine-inhibitable ALP. However, in both systems the false positive rate (control fluids with values below one third median), was unacceptably high. It is pointed out that at present the most effective system for the prenatal diagnosis of cystic fibrosis is achieved by measuring the ratio of intestinal to total ALP in amniotic fluid supernatants. This is probably best effected by enzymatic assay in the presence of phenylalanine and homoarginine inhibition.